Centessa Pharmaceuticals plc — Company profile
Healthcare · Biotechnology · United Kingdom
Last price 40.5 USD (At close: Jun 23, 2026) · Market cap 6.27B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Centessa Pharmaceuticals plc, together with its subsidiaries, discovers, develops, and delivers orexin-based neuroscience therapeutics in the United Kingdom and the United States. The company develops ORX750, an orexin receptor 2 agonist, which is in Phase IIa clinical trial for the treatment of central disorders of hypersomnolence, including narcolepsy type 1 and 2, as well as idiopathic hypersomnia. It also engages in the development of ORX142 which is in Phase I clinical trial for the treatment of neurological and neurodegenerative disorders; ORX489 which is in Phase I clinical trial for the treatment of neuropsychiatric disorders; and LockBody, an early-stage immuno-oncology program technology platform. The company was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.
Details
| Name | Centessa Pharmaceuticals plc |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 129 |
| Founded | 2020 |
| Ipo Date | 2021-05-28 |
| Ceo | Mario Accardi |
| Country | United Kingdom |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 20.00 |
| Isin | US1523091007 |
| Cusip | 152309100 |
| Cik | 1847903 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Dr. Mario Alberto Accardi Ph.D. | Chief Executive Officer and Director |
| John J. Crowley CPA | Chief Financial Officer |
| Dr. Stephen J. Kanes M.D., Ph.D. | Head of Research & Development and Chief Medical Officer |
| Raphael Deferiere CPA | Senior Vice President and Chief Accounting Officer |
| Tia L. Bush | Chief Technology and Quality Officer |
| Kristen K. Sheppard Esq., J.D. | Senior Vice President of Investor Relations and Corporate Communications |
| Iqbal J. Hussain L.L.B. | Chief Legal Officer, Chief Compliance Officer and Company Secretary |
| Karen M. Anderson | Chief People Officer |
| Dr. Gregory M. Weinhoff M.B.A., M.D. | Chief Business Officer |
| Charlene Stoudt | Senior Vice President of Clinical Development Operations |
Contact
| Address | 1 Ashley Road, 3rd Floor, Altrincham, WA14 2DT, United Kingdom |
| Website | https://centessa.com |